Fed. Circ. Lifts Lupin Ban In Generic Fortamet Fight
The Federal Circuit on Monday reversed an order requiring Lupin Ltd. to stop selling its generic version of Type 2 diabetes treatment Fortamet, vacating the preliminary injunction on grounds that the...To view the full article, register now.
Already a subscriber? Click here to view full article